NEW Paediatric Guideline: The initial immunosuppressive treatment for children and young people with immune mediated glomerular diseases
The UKKA guideline on The initial immunosuppressive treatment for children and young people with immune mediated glomerular diseases is now available.
NEW Guidelines: Anticoagulants in CKD
The UKKA guidelines on Anticoagulants in CKD are now available
- Anticoagulation for atrial fibrillation in adults with advanced kidney disease
- Anticoagulation for venous thromboembolism in adults with advanced kidney disease
CAKUT Guideline Scopes
We are inviting comments from members on two guideline draft scopes;
Any comments on the scopes can be sent to ukka@ukkidney.org, by 27th November.
CAKUT Guidelines - Expressions of Interest sought
Expressions of interest are also invited to develop new clinical guidelines for the postnatal management of the two conditions: Antenatal hydronephrosis / congenital single functioning kidney. We invite multidisciplinary representation from across adult and paediatric kidney care, including nephrology, urology (antenatal hydronephrosis only), radiology, fetal and neonatal medicine, genomics, dietetics (congenital single kidney only), nursing, midwifery, general practice (with or without an interest in nephrology).
To apply, please send a short statement explaining why you would like to be involved and what you feel you would bring to the guideline, along with a completed conflict of interest form to ukka@ukkidney.org by 27 November. Please include in the title of your email, which guideline you are interested in contributing to.
Please note: HCP's predominantly working in kidney care would be expected to hold a current UKKA membership.